Adaptimmune Therapeutics plc (ADAP) stock prices updated...
 

Adaptimmune Therapeutics plc stock price

Adaptimmune Therapeutics plc latest news:


  • 08/03/2017 06:26:50

    BRIEF-Adaptimmune reports Q2 revenue $3.5 million

    Adaptimmune Therapeutics Plc(ADAP): * Adaptimmune reports second quarter 2017 financial results. * Q2 revenue $3.5 million. * Q2 revenue view $5.4 million -- Thomson Reuters I/B/E/S. * Q2 loss per share $0.04. * Q2 earnings per share view $-0.25 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

  • More trends:

    Addus HomeCare CorporationADUS | ADDvantage Technologies Group, Inc.AEY | Adept Technology, Inc.ADEP | ADMA Biologics IncADMA | Adobe Systems IncorporatedADBE | ADTRAN, Inc.ADTN | Aduro Biotech, Inc.ADRO | Advanced Energy Industries, Inc.AEIS | Advanced Micro Devices, Inc.AMD | Advaxis, Inc.ADXS |